stonker
2021-08-26
Ooo
Purdue Pharma Says Its Bankruptcy Deal Is Fairest to Creditors<blockquote>普渡制药表示其破产协议对债权人最公平</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":810333567,"tweetId":"810333567","gmtCreate":1629943329659,"gmtModify":1631889730927,"author":{"id":3574899797175889,"idStr":"3574899797175889","authorId":3574899797175889,"authorIdStr":"3574899797175889","name":"stonker","avatar":"https://static.tigerbbs.com/bed6c0d56fcf5940d74693ce8e03a8b2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ooo</p></body></html>","htmlText":"<html><head></head><body><p>Ooo</p></body></html>","text":"Ooo","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/810333567","repostId":1126255492,"repostType":4,"repost":{"id":"1126255492","kind":"news","pubTimestamp":1629942614,"share":"https://www.laohu8.com/m/news/1126255492?lang=zh_CN&edition=full","pubTime":"2021-08-26 09:50","market":"us","language":"en","title":"Purdue Pharma Says Its Bankruptcy Deal Is Fairest to Creditors<blockquote>普渡制药表示其破产协议对债权人最公平</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1126255492","media":"Bloomberg","summary":"(Bloomberg) -- During the final day of argument in Purdue Pharma’s bankruptcy trial, lawyers for the","content":"<p>(Bloomberg) -- During the final day of argument in Purdue Pharma’s bankruptcy trial, lawyers for the OxyContin maker said its proposed $10 billion settlement of opioid claims is by far the best deal for creditors.</p><p><blockquote>(彭博)-在普渡制药公司破产审判的最后一天,奥施康定制造商的律师表示,其拟议的100亿美元阿片类药物索赔和解是迄今为止对债权人来说最好的交易。</blockquote></p><p> Seeking to convince U.S. Bankruptcy Judge Robert Drain that Purdue’s proposal is better than a liquidation of the business and free-for-all litigation stampede against itself and its owners, Marshall Huebner of Davis Polk & Wardwell, said the plan would deliver at least $5.5 billion of cash to creditors. The fact that most U.S. states now support the deal rather than pushing to continue their own “speculative” lawsuits shows the deal is sufficient, he added.</p><p><blockquote>Davis Polk&Wardwell的Marshall Huebner试图让美国破产法官Robert Drain相信普渡大学的提议比清算业务以及针对其自身及其所有者的免费诉讼要好,他表示该计划将至少带来55亿美元向债权人提供现金。他补充说,美国大多数州现在支持该协议,而不是推动继续自己的“投机性”诉讼,这一事实表明该协议已经足够了。</blockquote></p><p> “Except for lawyers, nobody does better in a liquidation,” Huebner said. “No one has ever said ‘I know a better way where creditors get more,’ or ‘I know a better way where victims get more redress,’” he said of the plan.</p><p><blockquote>“除了律师,没有人在清算中做得更好,”许布纳说。“从来没有人说过‘我知道债权人获得更多的更好方法’,或者‘我知道受害者获得更多赔偿的更好方法’,”他谈到该计划时说道。</blockquote></p><p> Still, about 10 state attorneys general are challenging the deal, arguing in large part that they should be able to sue Purdue’s owners, members of the billionaire Sackler family, regardless of the settlement. Purdue has said that wouldn’t work, because its owners are requiring broad legal immunity from opioid lawsuits in exchange for more than $4 billion of their own cash, and allowing some states to go forward would cause the entire settlement to unravel. Members of the Sackler family have previously denied any wrongdoing.</p><p><blockquote>尽管如此,大约10名州总检察长仍在对该交易提出质疑,他们在很大程度上认为,无论和解协议如何,他们都应该能够起诉普渡大学的所有者、亿万富翁萨克勒家族的成员。普渡大学表示,这是行不通的,因为其所有者要求阿片类药物诉讼的广泛法律豁免权,以换取超过40亿美元的自有现金,而允许一些州继续下去将导致整个和解协议破裂。萨克勒家族成员此前否认有任何不当行为。</blockquote></p><p> West Virginia Attorney General Patrick Morrisey took the podium on Wednesday to challenge the deal’s methodology for deciding how much money each state gets, arguing that West Virginia has been disproportionately harmed by opioids and should get a bigger piece of the settlement.</p><p><blockquote>西弗吉尼亚州总检察长帕特里克·莫里西(Patrick Morrisey)周三走上讲台,挑战该协议决定每个州获得多少资金的方法,认为西弗吉尼亚州受到阿片类药物的不成比例的伤害,应该在和解协议中获得更大的份额。</blockquote></p><p> “This is the number one issue facing our state,” Morrisey told Judge Drain. “What this court decides to do is likely going to set a precedent going forward” in other opioid litigation, he said.</p><p><blockquote>“这是我们州面临的头号问题,”莫里西告诉德雷恩法官。他说,“本法院决定做的事情可能会在其他阿片类药物诉讼中开创先例”。</blockquote></p><p> Before the hearing, lawyers for Purdue and members of the Sackler family said they further narrowed and more clearly defined the releases that would be granted under the plan, in response comments from Judge Drain. They also said they are continuing to work with those still opposing the plan, with the help of Judge Shelley Chapman as mediator, to resolve outstanding issues.</p><p><blockquote>在听证会之前,普渡大学的律师和萨克勒家族成员表示,他们进一步缩小并更明确地定义了根据该计划将批准的释放范围,以回应德莱恩法官的评论。他们还表示,在法官谢莉·查普曼作为调解人的帮助下,他们将继续与那些仍然反对该计划的人合作,以解决悬而未决的问题。</blockquote></p><p> Later in the hearing, Judge Drain became frustrated at the status of the releases that would be granted to the Sacklers and related entities, explaining that their most recent iteration is still too broad. “Time’s a wasting,” he said to a lawyer for one wing of the Sackler family.</p><p><blockquote>在听证会的晚些时候,德莱恩法官对萨克勒夫妇和相关实体的释放状态感到沮丧,并解释说他们最近的迭代仍然过于宽泛。“时间是在浪费,”他对萨克勒家族一派的律师说。</blockquote></p><p> Drain expects to rule on Purdue’s proposed settlement on Friday. That could be delayed if parties need more time to negotiate, he said.</p><p><blockquote>Drain预计将于周五对普渡大学提出的和解方案做出裁决。他说,如果各方需要更多时间进行谈判,这可能会被推迟。</blockquote></p><p> The bankruptcy case is Purdue Pharma LP, 19-23649, U.S. Bankruptcy Court for the Southern District of New York (White Plains).</p><p><blockquote>破产案件是普渡制药有限责任公司,19-23649,美国纽约南区破产法院(怀特普莱恩斯)。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Purdue Pharma Says Its Bankruptcy Deal Is Fairest to Creditors<blockquote>普渡制药表示其破产协议对债权人最公平</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPurdue Pharma Says Its Bankruptcy Deal Is Fairest to Creditors<blockquote>普渡制药表示其破产协议对债权人最公平</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-08-26 09:50</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- During the final day of argument in Purdue Pharma’s bankruptcy trial, lawyers for the OxyContin maker said its proposed $10 billion settlement of opioid claims is by far the best deal for creditors.</p><p><blockquote>(彭博)-在普渡制药公司破产审判的最后一天,奥施康定制造商的律师表示,其拟议的100亿美元阿片类药物索赔和解是迄今为止对债权人来说最好的交易。</blockquote></p><p> Seeking to convince U.S. Bankruptcy Judge Robert Drain that Purdue’s proposal is better than a liquidation of the business and free-for-all litigation stampede against itself and its owners, Marshall Huebner of Davis Polk & Wardwell, said the plan would deliver at least $5.5 billion of cash to creditors. The fact that most U.S. states now support the deal rather than pushing to continue their own “speculative” lawsuits shows the deal is sufficient, he added.</p><p><blockquote>Davis Polk&Wardwell的Marshall Huebner试图让美国破产法官Robert Drain相信普渡大学的提议比清算业务以及针对其自身及其所有者的免费诉讼要好,他表示该计划将至少带来55亿美元向债权人提供现金。他补充说,美国大多数州现在支持该协议,而不是推动继续自己的“投机性”诉讼,这一事实表明该协议已经足够了。</blockquote></p><p> “Except for lawyers, nobody does better in a liquidation,” Huebner said. “No one has ever said ‘I know a better way where creditors get more,’ or ‘I know a better way where victims get more redress,’” he said of the plan.</p><p><blockquote>“除了律师,没有人在清算中做得更好,”许布纳说。“从来没有人说过‘我知道债权人获得更多的更好方法’,或者‘我知道受害者获得更多赔偿的更好方法’,”他谈到该计划时说道。</blockquote></p><p> Still, about 10 state attorneys general are challenging the deal, arguing in large part that they should be able to sue Purdue’s owners, members of the billionaire Sackler family, regardless of the settlement. Purdue has said that wouldn’t work, because its owners are requiring broad legal immunity from opioid lawsuits in exchange for more than $4 billion of their own cash, and allowing some states to go forward would cause the entire settlement to unravel. Members of the Sackler family have previously denied any wrongdoing.</p><p><blockquote>尽管如此,大约10名州总检察长仍在对该交易提出质疑,他们在很大程度上认为,无论和解协议如何,他们都应该能够起诉普渡大学的所有者、亿万富翁萨克勒家族的成员。普渡大学表示,这是行不通的,因为其所有者要求阿片类药物诉讼的广泛法律豁免权,以换取超过40亿美元的自有现金,而允许一些州继续下去将导致整个和解协议破裂。萨克勒家族成员此前否认有任何不当行为。</blockquote></p><p> West Virginia Attorney General Patrick Morrisey took the podium on Wednesday to challenge the deal’s methodology for deciding how much money each state gets, arguing that West Virginia has been disproportionately harmed by opioids and should get a bigger piece of the settlement.</p><p><blockquote>西弗吉尼亚州总检察长帕特里克·莫里西(Patrick Morrisey)周三走上讲台,挑战该协议决定每个州获得多少资金的方法,认为西弗吉尼亚州受到阿片类药物的不成比例的伤害,应该在和解协议中获得更大的份额。</blockquote></p><p> “This is the number one issue facing our state,” Morrisey told Judge Drain. “What this court decides to do is likely going to set a precedent going forward” in other opioid litigation, he said.</p><p><blockquote>“这是我们州面临的头号问题,”莫里西告诉德雷恩法官。他说,“本法院决定做的事情可能会在其他阿片类药物诉讼中开创先例”。</blockquote></p><p> Before the hearing, lawyers for Purdue and members of the Sackler family said they further narrowed and more clearly defined the releases that would be granted under the plan, in response comments from Judge Drain. They also said they are continuing to work with those still opposing the plan, with the help of Judge Shelley Chapman as mediator, to resolve outstanding issues.</p><p><blockquote>在听证会之前,普渡大学的律师和萨克勒家族成员表示,他们进一步缩小并更明确地定义了根据该计划将批准的释放范围,以回应德莱恩法官的评论。他们还表示,在法官谢莉·查普曼作为调解人的帮助下,他们将继续与那些仍然反对该计划的人合作,以解决悬而未决的问题。</blockquote></p><p> Later in the hearing, Judge Drain became frustrated at the status of the releases that would be granted to the Sacklers and related entities, explaining that their most recent iteration is still too broad. “Time’s a wasting,” he said to a lawyer for one wing of the Sackler family.</p><p><blockquote>在听证会的晚些时候,德莱恩法官对萨克勒夫妇和相关实体的释放状态感到沮丧,并解释说他们最近的迭代仍然过于宽泛。“时间是在浪费,”他对萨克勒家族一派的律师说。</blockquote></p><p> Drain expects to rule on Purdue’s proposed settlement on Friday. That could be delayed if parties need more time to negotiate, he said.</p><p><blockquote>Drain预计将于周五对普渡大学提出的和解方案做出裁决。他说,如果各方需要更多时间进行谈判,这可能会被推迟。</blockquote></p><p> The bankruptcy case is Purdue Pharma LP, 19-23649, U.S. Bankruptcy Court for the Southern District of New York (White Plains).</p><p><blockquote>破产案件是普渡制药有限责任公司,19-23649,美国纽约南区破产法院(怀特普莱恩斯)。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://finance.yahoo.com/news/purdue-pharma-says-bankruptcy-deal-184708963.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/purdue-pharma-says-bankruptcy-deal-184708963.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126255492","content_text":"(Bloomberg) -- During the final day of argument in Purdue Pharma’s bankruptcy trial, lawyers for the OxyContin maker said its proposed $10 billion settlement of opioid claims is by far the best deal for creditors.\nSeeking to convince U.S. Bankruptcy Judge Robert Drain that Purdue’s proposal is better than a liquidation of the business and free-for-all litigation stampede against itself and its owners, Marshall Huebner of Davis Polk & Wardwell, said the plan would deliver at least $5.5 billion of cash to creditors. The fact that most U.S. states now support the deal rather than pushing to continue their own “speculative” lawsuits shows the deal is sufficient, he added.\n“Except for lawyers, nobody does better in a liquidation,” Huebner said. “No one has ever said ‘I know a better way where creditors get more,’ or ‘I know a better way where victims get more redress,’” he said of the plan.\nStill, about 10 state attorneys general are challenging the deal, arguing in large part that they should be able to sue Purdue’s owners, members of the billionaire Sackler family, regardless of the settlement. Purdue has said that wouldn’t work, because its owners are requiring broad legal immunity from opioid lawsuits in exchange for more than $4 billion of their own cash, and allowing some states to go forward would cause the entire settlement to unravel. Members of the Sackler family have previously denied any wrongdoing.\nWest Virginia Attorney General Patrick Morrisey took the podium on Wednesday to challenge the deal’s methodology for deciding how much money each state gets, arguing that West Virginia has been disproportionately harmed by opioids and should get a bigger piece of the settlement.\n“This is the number one issue facing our state,” Morrisey told Judge Drain. “What this court decides to do is likely going to set a precedent going forward” in other opioid litigation, he said.\nBefore the hearing, lawyers for Purdue and members of the Sackler family said they further narrowed and more clearly defined the releases that would be granted under the plan, in response comments from Judge Drain. They also said they are continuing to work with those still opposing the plan, with the help of Judge Shelley Chapman as mediator, to resolve outstanding issues.\nLater in the hearing, Judge Drain became frustrated at the status of the releases that would be granted to the Sacklers and related entities, explaining that their most recent iteration is still too broad. “Time’s a wasting,” he said to a lawyer for one wing of the Sackler family.\nDrain expects to rule on Purdue’s proposed settlement on Friday. That could be delayed if parties need more time to negotiate, he said.\nThe bankruptcy case is Purdue Pharma LP, 19-23649, U.S. Bankruptcy Court for the Southern District of New York (White Plains).","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1271,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/810333567"}
精彩评论